NICOLE FULLER: Open Payments
NPI 1386350742 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,917 in 83 payments from 19 companies in 2025. Trend: 2023 $1,030 · 2024 $2,108 · 2025 $1,917
Food & beverage: $1,836Education: $81
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $289 |
| Regeneron Healthcare Solutions, Inc. | 5 | $281 |
| Incyte Corporation | 9 | $247 |
| UCB, Inc. | 8 | $173 |
| ABBVIE INC. | 12 | $159 |
| Organon LLC | 10 | $123 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $108 |
| GENZYME CORPORATION | 3 | $104 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| Botanix SB Inc | 3 | $73 |
Products named: DUPIXENT, TREMFYA, OPZELURA, Bimzelx, SKYRIZI, ILUMYA, SOFDRA, VTAMA.
Industry payments across PA — which companies pay providers there.
